Results 211 to 220 of about 493,419 (345)

Neo-colonialism and financing for the war on drugs: a review of current policy and recommendations for countries in the global north. [PDF]

Harm Reduct J
Daniels C, Burke-Shyne N, Cook C, Beattie A.   +3 more
europepmc   +1 more source

The Myth of Transformation Through EU Law: A Case-Study of the Company Law Reform in Ukraine

, 2009
Leonid Antonenko
openalex   +1 more source

Market potential of biobased chemicals: a qualitative network analysis of adoption dynamics in South Africa’s bioeconomy

Biofuels, Bioproducts and Biorefining, EarlyView.
Abstract The premise of a bioeconomy is the replacement of nonrenewable and unsustainable fossil‐derived resources and associated technologies with more sustainable alternatives. The adoption of biobased chemicals contributes toward the growth of a bioeconomy and is dependent on market and industry requirements.
Prisha Mandree, George Alex Thopil, Santosh Ramchuran   +2 more
wiley   +1 more source

Evaluating the corporate social responsibility agenda for high-cost novel therapies: roles for government and civil society. [PDF]

Health Res Policy Syst
Wong A, Saeed G, Garner S, Kohler J.
europepmc   +1 more source

Anglo-American and Continental European approaches of company law in cross-border regulations in the EU

, 2016
Orkhan Afandi
openalex   +1 more source

Status of oncology drugs with a conditional approval: A cross‐sectional comparison of the Food and Drug Administration and Health Canada

British Journal of Clinical Pharmacology, EarlyView.
Aims This study looks at the status of the same drugs conditionally approved by the Food and Drug Administration and Health Canada for the same oncology indication. Methods Lists of oncology drugs with a conditional approval from the Food and Drug Administration and Health Canada were generated and drug pairs with the same indication were matched ...
Joel Lexchin
wiley   +1 more source

Decentralized Clinical Trials: Governance, Ethics and Medico-Legal Issues for the New Paradigm of Research with a Focus on Cardiovascular Field. [PDF]

Med Sci (Basel)
Tenti E, Basile G, Giorgetti C, Sangiorgi D, Mikus E, Sebastiani G, Bolcato V, Tronconi LP, Tremoli E.   +8 more
europepmc   +1 more source

Book of the seminar on the evaluation of the results regarding chapter 6 (company law) in the progress reports of the EU acquis harmonization process: TUBITAK 3005 Project-Project No: 123K011-2023

, 2023
Yıldız, Şükrü, Bozkır, Betül, Kol, Hüseyin Yağızhan   +2 more
openalex   +1 more source

Paradigm Shift in Global Governance of Medical Brain-Computer Interface: Addressing Practical Challenges Through Institutional Innovation. [PDF]

Risk Manag Healthc Policy
Zhu R, Zhao Y, Li Y.
europepmc   +1 more source

An open‐label, single‐arm, dose‐escalating concentration–QT study to investigate the cardiac effects and safety of paroxetine in healthy adults

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aims Paroxetine is a selective serotonin reuptake inhibitor (SSRI), approved for treatment of major depressive disorder and anxiety disorders. Some SSRIs are known to prolong the QT interval; however, clinical evidence to establish a lack of association between paroxetine and corrected QT interval (QTc) prolongation is limited. Therefore, this
Sven C. van Dijkman, Mathieu Félices, Bhaskar Pandurangavittal, Sanman Ghorpade, Caroline Easterbrook, Marcin Zabielski, Oscar Della Pasqua   +6 more
wiley   +1 more source